Positron Emission Tomograph(PET) Imaging Explores the Role of SF-DEVD-2 in Monitoring Tumor Efficacy

NCT05828238 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer Stage II
Breast Cancer Stage III
Solid Tumor

Interventions

DRUG: [18F]SF-DEVD-2
DRUG: [18F]-FDG

Sponsor

Affiliated Hospital of Jiangnan University